Retention among North American HIV-infected persons in clinical care, 2000-2008

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 3, 2013, Pages 356-362

  Rebeiro, Peter ^a   Althoff, Keri N ^a   Buchacz, Kate ^b   Gill, John ^c   Horberg, Michael ^d   Krentz, Hartmut ^e   Moore, Richard ^f   Sterling, Timothy R ^g   Brooks, John T ^b   Gebo, Kelly A ^f   Hogg, Robert ^h   Klein, Marina ⁱ   Martin, Jeffrey ^j   Mugavero, Michael ^k   Rourke, Sean ^l   Silverberg, Michael J ^d   Thorne, Jennifer ^a   Gange, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h SIMON FRASER UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k and Clinical Center   (United States)

^l UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Churn; HIV clinical care; HRSA HAB; National HIV AIDS strategy; North America; Retention

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE; ARTICLE; CANADA; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEGRO; PATIENT CARE; PRIORITY JOURNAL; RACE; UNITED STATES;

EID: 85027942899     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827f578a     Document Type: Article

References (23)

1. Stone VE. HIV/AIDS in women and racial/ethnic minorities in the U.S. Curr Infect Dis Rep. 2012;14:53-60.
2. Berg MB, Safren SA, Mimiaga MJ, et al. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care. 2005;17:902-907.
3. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44: 1493-1499.
4. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009;50:100-108.
5. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248-256.
6. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23:41-49.
7. CDC. Vital signs: HIV prevention through care and treatment-United States. MMWR. 2011;60:1618-1623.
8. Hall HI, Gray KM, Tang T, et al. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60:77-82.
9. Gill MJ, Krentz HB. Unappreciated epidemiology: the churn effect in a regional HIV care programme. Int J STD AIDS. 2009;20:540-544.
10. US Department of Health and Human Services, Health Resources and Services Administration HIV/AIDS Bureau. HAB HIV Performance Measures: Medical Case Management. Available at: http://hab.hrsa.gov/-deliverhivaidscare/files/ habpmsmedicalcaseplan.pdf Accessed November 23, 2009.
11. Dombrowski JC, Kent JB, Buskin SE, et al. Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2012;26:77-86.
12. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007;36:294-301.
13. The White House Office of National AIDS Policy. The National HIV/AIDS Strategy. Washington, DC: The White House; 2010.
14. The Canadian Public Health Association. Leading Together: Canada Takes Action on HIV/AIDS (2005-2010). Ottawa, Ontario, Canada: The Public Health Agency of Canada; 2005.
15. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012; 156:817-833.
16. Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. AIDS Res Hum Retroviruses. 2007;23:769-776.
17. Mugavero MJ, Davila JA, Nevin CR, et al. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS. 2010;24:607-613.
18. Institute of Medicine of the National Academies. Monitoring HIV Care in the United States, Indicators and Data Systems. [Table 1: "Core Indicators of HIV Clinical Care"]. Washington, DC: National Academies Press; 2012.
19. Gange SJ, Muñoz A, Saez M, et al. Use of the beta-binomial distribution to model the effect of policy changes on appropriateness of hospital stays. J R Stat Soc Ser C Appl Stat. 1996;45:371-382.
20. Xue X, Gange SJ, Zhong Y, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev. 2010;19:159-169.
21. Skrondal A, Rabe-Hesketh S. Some applications of generalized linear latent and mixed models in epidemiology: repeated measures, measurement error and multilevel modeling. Nor Epidemiol. 2003;13:265-278.
22. Krentz HB, Siemieniuk RA, Gill MJ. Similar challenges with retention in care issues. Clin Infect Dis. 2007;45:1527.
23. Althoff KN, Buchacz K, Hall HI, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 2012;157:325-335.